Literature DB >> 32357956

Prevalence of Cigarette Smoking among Patients with Different Histologic Types of Kidney Cancer.

Ted Gansler1, Stacey A Fedewa2, W Dana Flanders3, Lori A Pollack4, David A Siegel4, Ahmedin Jemal2.   

Abstract

BACKGROUND: Cigarette smoking is causally linked to renal cell carcinoma (RCC). However, associations for individual RCC histologies are not well described. Newly available data on tobacco use from population-based cancer registries allow characterization of associations with individual RCC types.
METHODS: We analyzed data for 30,282 RCC cases from 8 states that collected tobacco use information for a National Program of Cancer Registry project. We compared the prevalence and adjusted prevalence ratios (aPR) of cigarette smoking (current vs. never, former vs. never) among individuals diagnosed between 2011 and 2016 with clear cell RCC, papillary RCC, chromophobe RCC, renal collecting duct/medullary carcinoma, cyst-associated RCC, and unclassified RCC.
RESULTS: Of 30,282 patients with RCC, 50.2% were current or former cigarette smokers. By histology, proportions of current or formers smokers ranged from 38% in patients with chromophobe carcinoma to 61.9% in those with collecting duct/medullary carcinoma. The aPRs (with the most common histology, clear cell RCC, as referent group) for current and former cigarette smoking among chromophobe RCC cases (4.9% of our analytic sample) were 0.58 [95% confidence interval (CI), 0.50-0.67] and 0.88 (95% CI, 0.81-0.95), respectively. Other aPRs were slightly increased (papillary RCC and unclassified RCC, current smoking only), slightly decreased (unclassified RCC, former smoking only), or not significantly different from 1.0 (collecting duct/medullary carcinoma and cyst-associated RCC).
CONCLUSIONS: Compared with other RCC histologic types, chromophobe RCC has a weaker (if any) association with smoking. IMPACT: This study shows the value of population-based cancer registries' collection of smoking data, especially for epidemiologic investigation of rare cancers. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32357956     DOI: 10.1158/1055-9965.EPI-20-0015

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Truncating CDKN1A mutations: an insight into the biology of urinary tract carcinomas?

Authors:  Omar Alhalabi; Pavlos Msaouel
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population.

Authors:  Mikhlid H Almutairi; Bader O Almutairi; Turki M Alrubie; Sultan N Alharbi; Narasimha R Parine; Abdulwahed F Alrefaei; Ibrahim Aldeailej; Abdullah Alamri; Abdelhabib Semlali
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

3.  Association of Cigarette Use and Substance Use Disorders among US Adults with and without a Recent Diagnosis of Cancer.

Authors:  Joanna M Streck; Maria A Parker; Andrea H Weinberger; Nancy A Rigotti; Elyse R Park
Journal:  Curr Oncol       Date:  2020-12-12       Impact factor: 3.677

Review 4.  Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis.

Authors:  Divya Jain; Priya Chaudhary; Nidhi Varshney; Khandaker Sabit Bin Razzak; Devret Verma; Tasnim Reza Khan Zahra; Pracheta Janmeda; Javad Sharifi-Rad; Sevgi Durna Daştan; Shafi Mahmud; Anca Oana Docea; Daniela Calina
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

5.  Family History of Cancers Increases Risk of Renal Cell Carcinoma in a Chinese Population.

Authors:  Siwei Xing; Xiaohao Ruan; Jingyi Huang; Jiaqi Yan; Wenhao Lin; Jinlun Huang; Jiacheng Liu; Da Huang; Rong Na; Danfeng Xu
Journal:  Cancer Manag Res       Date:  2022-08-30       Impact factor: 3.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.